261 related articles for article (PubMed ID: 37540751)
1. Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis.
Oiwa K; Watanabe S; Onodera K; Iguchi Y; Kinoshita Y; Komine O; Sobue A; Okada Y; Katsuno M; Yamanaka K
Sci Adv; 2023 Aug; 9(31):eadf6895. PubMed ID: 37540751
[TBL] [Abstract][Full Text] [Related]
2. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
3. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R
Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555
[TBL] [Abstract][Full Text] [Related]
4. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
5. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
6. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
[TBL] [Abstract][Full Text] [Related]
8. Mice deficient in the C-terminal domain of TAR DNA-binding protein 43 develop age-dependent motor dysfunction associated with impaired Notch1-Akt signaling pathway.
Nishino K; Watanabe S; Shijie J; Murata Y; Oiwa K; Komine O; Endo F; Tsuiji H; Abe M; Sakimura K; Mishra A; Yamanaka K
Acta Neuropathol Commun; 2019 Jul; 7(1):118. PubMed ID: 31345270
[TBL] [Abstract][Full Text] [Related]
9. Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids.
Tamaki Y; Ross JP; Alipour P; Castonguay CÉ; Li B; Catoire H; Rochefort D; Urushitani M; Takahashi R; Sonnen JA; Stifani S; Dion PA; Rouleau GA
PLoS Genet; 2023 Feb; 19(2):e1010606. PubMed ID: 36745687
[TBL] [Abstract][Full Text] [Related]
10. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and pathological spectrum of TDP-43 associated ALS].
Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
13. In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS).
Don EK; Maschirow A; Radford RAW; Scherer NM; Vidal-Itriago A; Hogan A; Maurel C; Formella I; Stoddart JJ; Hall TE; Lee A; Shi B; Cole NJ; Laird AS; Badrock AP; Chung RS; Morsch M
Mol Neurobiol; 2021 May; 58(5):2061-2074. PubMed ID: 33415684
[TBL] [Abstract][Full Text] [Related]
14. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
15. Mutation in the RRM2 domain of TDP-43 in Amyotrophic Lateral Sclerosis with rapid progression associated with ubiquitin positive aggregates in cultured motor neurons.
Maurel C; Madji-Hounoum B; Thepault RA; Marouillat S; Brulard C; Danel-Brunaud V; Camdessanche JP; Blasco H; Corcia P; Andres CR; Vourc'h P
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):149-151. PubMed ID: 28705014
[TBL] [Abstract][Full Text] [Related]
16. Characteristic Features of FUS Inclusions in Spinal Motor Neurons of Sporadic Amyotrophic Lateral Sclerosis.
Ikenaka K; Ishigaki S; Iguchi Y; Kawai K; Fujioka Y; Yokoi S; Abdelhamid RF; Nagano S; Mochizuki H; Katsuno M; Sobue G
J Neuropathol Exp Neurol; 2020 Apr; 79(4):370-377. PubMed ID: 32142134
[TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology.
Tudor EL; Galtrey CM; Perkinton MS; Lau KF; De Vos KJ; Mitchell JC; Ackerley S; Hortobágyi T; Vámos E; Leigh PN; Klasen C; McLoughlin DM; Shaw CE; Miller CC
Neuroscience; 2010 May; 167(3):774-85. PubMed ID: 20188146
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.
Kim HC; Zhang Y; King PH; Lu L
J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420
[TBL] [Abstract][Full Text] [Related]
19. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.
Bennett CL; Dastidar SG; Ling SC; Malik B; Ashe T; Wadhwa M; Miller DB; Lee C; Mitchell MB; van Es MA; Grunseich C; Chen Y; Sopher BL; Greensmith L; Cleveland DW; La Spada AR
Acta Neuropathol; 2018 Sep; 136(3):425-443. PubMed ID: 29725819
[TBL] [Abstract][Full Text] [Related]
20. TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS.
Droppelmann CA; Campos-Melo D; Moszczynski AJ; Amzil H; Strong MJ
Sci Rep; 2019 Dec; 9(1):19928. PubMed ID: 31882736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
